Analyst Reco. Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
10.88 ^USD	+1.59%		+3.92%	+25.64%

Apr. 19	Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target	MT
Apr. 01	BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target	Apr. 19	MT
BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating	Apr. 01	MT
Needham Adjusts Price Target on Cellebrite to $13.50 From $13, Keeps Buy Rating	Mar. 28	MT
William Blair Upgrades Cellebrite DI to Outperform From Market Perform	Mar. 13	MT
BofA Securities Upgrades Cellebrite to Buy From Neutral on Solid Q4 Earnings, Business Momentum, Raises PT to $12 From $9	Feb. 16	MT
Deutsche Bank Raises Cellebrite DI Price Target to $13 From $10, Maintains Buy Rating	Feb. 16	MT
Deutsche Bank Adjusts Cellebrite DI Price Target to $9 From $6.50, Maintains Buy Rating	23-08-09	MT
Needham Adjusts Price Target on Cellebrite DI to $10 From $7, Keeps Buy Rating	23-08-09	MT
Craig-Hallum Starts Cellebrite DI at Buy With $11 Price Target	23-07-19	MT
Needham Adjusts Cellebrite DI Price Target to $7 From $6.50, Maintains Buy Rating	23-03-14	MT
Deutsche Bank Adjusts Cellebrite DI Price Target to $6.50 From $6, Maintains Buy Rating	23-02-16	MT
Deutsche Bank Adjusts Cellebrite DI's Price Target to $6 From $7, Maintains Buy Rating	23-01-17	MT
BofA Securities Downgrades Cellebrite DI to Neutral	22-08-12	MT
Deutsche Bank Adjusts Cellebrite's Price Target to $7 From $10, Maintains Buy Rating	22-08-12	MT
Cowen Adjusts Price Target on Cellebrite DI to $10 From $13, Keeps Outperform Rating	22-08-12	MT
William Blair Downgrades Cellebrite DI to Market Perform From Outperform	22-08-12	MT
Needham Adjusts Cellebrite DI's Price Target to $6 from $9.50, Keeps Buy Rating	22-05-13	MT
JPMorgan Starts Cellebrite DI at Overweight With $10.50 Price Target	22-02-24	MT
Deutsche Bank Adjusts Cellebrite DI's Price Target to $11 From $10.50, Maintains Buy Rating	22-02-17	MT
Deutsche Bank Initiates Coverage on Cellebrite DI With Buy Rating, $10.50 Price Target	22-02-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cellebrite DI Ltd.

Equities

CLBT

IL0011794802

Analyst Reco.

Filters